This article examines the pathogenesis and diagnosis of overweight in metabolic syndrome, highlighting non-drug and drug therapies.
This article analyzes current understanding of the pathogenesis, diagnosis, and impact on prognosis of overweight in metabolic syndrome. It provides an overview of current diagnostic potential, non-drug and drug therapy for overweight, and the cardiovascular benefits of drugs used to reduce body weight.
No takes yet. Share an insight, caveat, or question.
Недогода et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: